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ABSTRACT
Multispacer typing (MST) was used to type 10  Francisella tularensis strains detected in 
French  patients.  Incorporating  79  Swedish  F.  tularensis strains,  phylogenetic  analysis 
demonstrated that that in spite tularemia appears as a sporadic disease in France, it is caused by 
an epidemic cluster of strains.
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Francisella  tularensis,  the  causative  agent  of  tularemia  in  mammalian  species,  is  a 
facultative intracellular  bacterial  species.  Four  subspecies  of  F. tularensis,  subsp.  tularensis, 
subsp.  holarctica,  subsp.novicida,  and subsp.  mediasiatica,  have been identified and each of 
them has distinct  virulence and geographic distribution (1).  Human tularemia is  endemic in 
certain areas of the northern hemisphere and may be present in various clinical forms depending 
on the route of inoculation and the virulence of the F. tularensis strains involved (2). The less 
frequent but more severe clinical form, respiratory tularemia (type A tularemia), is caused by 
inhalation of highly virulent  F. tularensis subsp.  tularensis and has mainly been identified in 
Northern America (2). The most common clinical manifestation of F. tularensis infection, type B 
tularemia, is caused by F. tularensis subsp. holarctica. It is usually contracted from the bite of an 
arthropod vector that previously fed on an infected animal or contact with infected animals. 
Type B tularemia is characterized by the development of a local painful lesion at the site of 
inoculation,  tender  regional  lymphadenopathy,  fever  and  other  constitutional  symptoms 
including  malaise,  headache,  anorexia,  and  myalgia  (3).  Type  B  tularemia  is  endemic  to 
countries of the Northern Hemisphere and is rarely life threatening but may lead to long-lasting 
complications (e.g., lymph node suppuration). In France, tularemia is a rare and mostly sporadic 
disease and only type B tularemia has been reported (4). Several animal outbreaks have been 
recorded  (5).  In  2004,  an  outbreak  of  airborne  tularemia  caused  by  F.  tularensis  subsp. 
holarctica occured in western France, which suggested a transmission from dog to humans by 
inhalation of contaminated particles from the dog’s fur (6).
While each subspecies of F. tularensis has distinct virulence and geographic distribution, the 
genetic difference among them is minor, making individual discrimination of F. tularensis 
strains and epidemiological surveillance of tularemia extremely difficult (7). Multispacer typing 
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(MST) incorporating four highly variable intergenic spacers which were selected by genome 
comparison exhibited more powerful capacity of individual discrimination of F. tularensis 
strains and more reasonable subspecies classification than multilocus variable number tandem 
repeat analysis (MLVA) (8). In this study, MST was tested to direct typing of F. tularensis strains 
detected in human specimens in France.
This study was performed after agreement of the ethical committee of IFR 48 under 08-
014. Ten French patients with swollen lymph nodes and with diagnosis of type B tularemia on 
the basis of clinical manifestations and serological test in 2008 were included in this study. 
Lymph node biopsies from these patients were frozen at -20°C then referred to our laboratory.
Total genomic DNA was extracted from the lymph nodes using QIAamp Tissue kit 
(QIAGEN, Hilden, Germany) according to the manufacturer’s recommendations. Specific PCR 
detection of F. tularensis on the DNA extracts was performed using a real-time quantitative PCR 
assays targeting the 17kDa major membrane protein precursor of the bacterium. This PCR 
included the primers Tul4F (ATTACAATGGCAGGCTCCAGA) and Tul4R 
(TGCCCAAGTTTTATCGTTCTTCT) and a Taqman probe (Tul4, 6-FAM-
TTCTAAGTGCCATGATACAAGCTTCCCAATTACTAA-TAMRA). PCR was done in a 
LightCycler instrument (Roche Biochemicals, Mannheim, Germany).The PCR mixture included 
a final volume of 20μl with 10μl of the Probe Master kit (Qiagen), 0.5μl (10pmol/μl) of each 
primer, 5μl (2μmol/μl) of probe, 3μl of distilled water, and 2μl of extracted DNA. The 
amplification conditions were as follows: an initial denaturation step at 95°C for 15 min, 
followed by 40 cycles of denaturation at 95°C, annealing and elongation at 60°C for 60s, with 
fluorescence acquisition in single mode. After every five patients samples, negative controls 
(sterile distilled water, PCR mix, and biopsy samples from healthy humans) were inserted. MST 
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incorporating 4 highly variable intergenic spacers, S1, S2, S3, and S4, which were selected by 
genome comparison was performed as previously described (9). Briefly, these 4 highly variable 
intergenic spacers were amplified and sequenced from the genomic DNA of each lymph node 
biopsy. The sequence variations of concatenation of these four intergenic spacers were then used 
for discrimination of F. tularensis strains detected in these lymph node biopsies. A MST 
genotype is defined as unique sequence variation of concatenation of these four intergenic 
spacers. Phylogenetic organization of the 10 French strains in this study and the 79 strains 
collected in Sweden and one strain collected in France in previous study was inferred on the 
basis of concatenation of these 4 intergenic spacer sequences using the UPGMA, Neighbor-
Joining and Maximum Parsimony methods within the MEGA 4.1 software. We added to the 
present analysis the 4 intergenic spacer sequences of F. tularensis subsp. tularensis strain Schu 
4, F. tularensis subsp.novicida strain GA99-3549, and F. tularensis subsp. mediasiatica strain 
FSC147 with GenBank accession numbers, NC_006570, NZ_AAYF00000000, and 
NC_010677, respectively.
MST, a DNA sequence-based genotyping method using highly variable intergenic spacers 
as typing markers which are selected on the basis of genome comparison, is a byproduct of 
genome biology in the genomic era (10). Since 2004, MST has been applied to several important 
human pathogenic bacteria and exhibited great power for strain typing. In our previous study, 
MST represented by four highly variable spacers showed good discriminatory power and gave a 
consistent phylogenetic classification of the studied strains (9). Using this technique, we 
identified 4 new genotypes of spacer S1, types 19-22, but no new genotype of spacers S2, S3, 
and S4 (Figure 1). Newly identified genotypes of each spacer identified in the present study 
were deposited in GenBank (accession number: EU877932- EU877935). In total, 4 new MST 
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genotypes were identified among the 10 French strains (Figure 1). The sequence identity of 
concatenation of 4 intergenic spacers of 11 French strains is higher as compared to that of 79 
Swedish strains with 97.39% versus 88.62% respectively (Table 1). Phylogenetic analysis based 
on different methods exhibits similar organization. The 31 MST genotypes identified in French 
and Sweden strains of subsp. holarctica were grouped into 3 clusters and F. tularensis subsp. 
tularensis, F. tularensis subsp. mediasiatica, and F. tularensis subsp. novicida formed outgroups, 
respectively (Figure 1). Interestingly, the eleven French strains grouped tightly into one cluster 
and all the 79 Sweden strains were grouped into 2 other Swedish clusters, respectively (Figure 
1).
In our analysis of F. tularensis subsp. holarctica, we found that one cluster is unique to 
French strains which exhibit relatively lower genetic diversity than previously typed Swedish 
strains (Table 1 and Figure 1). This confirms that French cases of tularemia that appear as rare 
and sporadic, is in fact an epidemic due to closely related strains as previously observed in 
central and western Europe (11). In France, tularemia is a notifiable disease. Every year, 
between 20 and 40 cases are reported (http://invs.sante.fr/surveillance/tularemie/default.htm). 
Direct diagnosis is done in approximately 20% of cases, mostly by PCR but only 1-3 F. 
tularensis strains are isolated yearly due to the fastidious cultural properties of F. tularensis. The 
difficulty of isolation and culture of F. tularensis from human specimens further hinders 
epidemiological surveillance because many molecular typing approaches are based on cultivated 
strains (10). Dempsey et. al identified a 1.59kb genomic deletion specific to F. tularensis subsp. 
holarctica isolates from France and Spain and classified these isolates into an emerging 
subclone in France and Iberian Peninsula (12). The same picture was observed for strains from 
Switzerland and France, countries where the epidemic clone was present before the tularemia 
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outbreak of 1997-1998 in the Iberian Peninsula (11). Our study further supports that the F. 
tularensis subsp. holarctica strains in France are an emerging subclone. Identification of several 
subclusters among F. tularensis subsp. holarctica also confirms that it is a dynamic subspecies 
rather than a homogeneous group as observed in F. tularensis subsp. tularensis in which two 
subpopulations were identified (13). The non homogeneous structure of F. tularensis subsp. 
holarctica population was also recently observed in Japan by using MLVA and in a global study 
using microarray SNP genotyping (14;15). This study confirms the usefulness of MST in 
epidemiological study of F. tularensis infection in France and even in Europe where tularemia is 
mainly caused by subsp holarctica, a particularly conserved subspecies (7). To obtain a clearer 
population structure of F. tularensis subsp. holarctica, MST, that requires performing four short 
sequences for powerful discrimination, may be useful in the future large scale epidemiologic 
studies incorporating a large number of strains.
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Table 1. Comparison of genetic diversity of French and Swedish strains of  F. tularensis 
subsp. holarctica by DNA sequence variation, number of MST genotype, and number of cluster 
based on four highly variable intergenic spacers.
F. tularensis subsp. 
holarctica strains
Strain number* Number of MST 
genotype*
Number of 
cluster*
Sequence 
identity**
Sequence 
difference**
French strains 11 5 1 97.39% 2.61%
Swedish strains 79 26 2 88.62% 11.38%
 * also see Figure 1
 ** The DNA sequence identity and difference of concatenation of 4 intergenic spacers were 
generated by sequence alignment using Clustal W program (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=/NPSA/npsa_clustalwan.html).
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Figure 1. Dendrogram showing the phylogenetic organization of the studied 10 French strains 
of F. tularensis subsp holarctica with 80 strains of F. tularensis subsp holarctica from previous 
study (9) and F. tularensis subsp. tularensis strain Schu 4, F. tularensis subsp. mediasiatica 
strain GA99-3549, and F. tularensis subsp.novicida strain FSC147 which have genome 
sequences in GenBank. Sequences from the four intergenic spacers were concatenated. 
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